C. Harvengt

发表

Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor).

Y. Horsmans, J. Desager, C. Harvengt, 1990, Pharmacology & toxicology.

Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic

P. Hermann, J. Desager, C. Harvengt, 1988, Psychopharmacology.

Colestipol in familial type II hyperlipoproteinemia: A three‐year trial

J. Desager, C. Harvengt, 1976, Clinical pharmacology and therapeutics.

Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicin.

Y. Horsmans, J. Desager, C. Harvengt, 1992, Pharmacology & toxicology.

Immunoquantification of cytochrome P-450 3A on rat paraffin-embedded liver tissue.

Y. Horsmans, J. Rahier, A. Geubel, 2008, Liver.

The vitamin A fat-loading test in young normolipidemic subjects.

J. Desager, C. Vandenplas, C. Harvengt, 1993, Clinica chimica acta; international journal of clinical chemistry.

Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus.

C. Harvengt, 1992, Diabete & metabolisme.

Uricosuric Effect of Fenofibrate in Healthy Volunteers

J. Desager, C. Harvengt, R. Hulhoven, 1980, Journal of clinical pharmacology.

Beta-blocking agents and plasma lipids: an update.

J. Desager, C. Harvengt, F. Heller, 1987, Advances in experimental medicine and biology.

High density lipoprotein and atherosclerosis.

C. Harvengt, 1978, Acta clinica Belgica.

Oestroprogestogens and serum lipoproteins

C. Harvengt, F. Heller, 1984 .

Influence of Fasting on Adrenocortical and Pancreatic Islet Response to Glucose Loads in the Obese *

C. Harvengt, M. Gasparo, J. Crabbé, 1970, European journal of clinical investigation.

Short‐Term Effects of Beta Blockers Atenolol, Nadolol, Pindolol, and Propranolol on Lipoprotein Metabolism in Normolipemic Subjects

C. Harvengt, F. Heller, Philippe Martial, 1987, Journal of clinical pharmacology.

Lecithin: Cholesterol Acyltransferase Activity in Familial Hypercholesterolemia Treated with Simvastatin and Simvastatin Plus Low‐Dose Colestipol

Y. Horsmans, J. Desager, C. Harvengt, 1991, Journal of clinical pharmacology.

Effect of hemodialysis on plasma kinetics of fenofibrate in chronic renal failure.

J. Desager, C. Harvengt, R. Verberckmoes, 1982, Nephron.

Lack of effect by nifedipine on hepatic mixed function oxidase in man

S. Pauwels, Y. Horsmans, J. Desager, 1991, Fundamental & clinical pharmacology.

Sympathetic nervous system response in acute cardiovascular toxicity induced by amitriptyline in conscious rabbits.

J. Desager, C. Harvengt, M. Bogaert, 1978, Toxicology and applied pharmacology.

Scoparone O-demethylase assay is not useful to differentiate the effects of model inducers of cytochrome P-450 in rabbit and guinea pig liver.

Y. Horsmans, J. Desager, C. Harvengt, 1993, Life sciences.

Effects of simvastatin and pravastatin on 6 beta-hydroxycortisol excretion, a potential marker of cytochrome P-450 3A.

Y. Horsmans, J. Desager, C. Harvengt, 1993, Pharmacological research.

Cholesteryl ester transfer in atherosclerosis.

J. Etienne, C. Harvengt, F. Heller, 1987, Advances in experimental medicine and biology.

Plasma lipid concentrations and lecithin:cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipol.

J. Desager, C. Harvengt, F. Heller, 1981, Metabolism: clinical and experimental.

Simvastatin use in children

E. Muls, J. Chaudron, D. Brasseur, 1992, The Lancet.

Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.

C. Harvengt, V. Leclercq, 1989, International journal of clinical pharmacology, therapy, and toxicology.

Parallel changes of atrial natriuretic factor and catecholamines during surgery for pheochromocytoma.

J. Ketelslegers, M. Buysschaert, J. Donckier, 1988, The American journal of medicine.

Oral Bioavailability of Nizatidine and Ranitidine Concurrently Administered with Antacid

J. Desager, C. Harvengt, 1989, The Journal of international medical research.

Effects of gemfibrozil on plasma lipoproteins, plasma activities of hepatic enzymes, and hemostatic variables in hypertriglyceridemic patients

O. Descamps, J. Desager, C. Harvengt, 1995 .

Absolute bioavailability of amiodarone in normal subjects

J. Desager, C. Harvengt, Y. Berger, 1985, Clinical pharmacology and therapeutics.

Relative acute cardiovascular toxicity induced by maprotiline, mianserin and nomifensine in conscious rabbits.

J. Desager, C. Harvengt, 1983, Journal of toxicology. Clinical toxicology.

Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days.

Y. Horsmans, J. Desager, C. Vandenplas, 1996, Atherosclerosis.

The urinary 6 beta-hydroxycortisol excretion in man on inducers and inhibitors of the hepatic mixed function oxidase.

J. Desager, C. Harvengt, E. Dumont, 1987, Pharmacology & therapeutics.

Reduced cardiac output and renal blood flow during amitriptyline intoxication in conscious rabbits.

J. Desager, C. Harvengt, J. P. Leonard, 1979, Toxicology and applied pharmacology.

Drugs recently released in Belgium.

C. Harvengt, 1983, Acta clinica Belgica.

Clinical pharmacokinetic study of procetofene, a new hypolipidemic drug, in volunteers.

J. Desager, C. Harvengt, 1978, International journal of clinical pharmacology and biopharmacy.

Plasma activities of lipoprotein lipase, hepatic lipase and lecithin: cholesterol acyltransferase in patients considered for parenteral nutrition with fat emulsion.

M. Reynaert, C. Harvengt, F. Heller, 1985, The American journal of clinical nutrition.

Effects of gemfibrozil on the activities of plasma lipolytic enzymes in normolipidemic subjects.

Y. Horsmans, J. Desager, C. Harvengt, 1993, Clinica chimica acta; international journal of clinical chemistry.

D-propoxyphene and norpropoxyphene kinetics after the oral administration of D-propoxyphene: a new approach to liver function?

Y. Horsmans, J. Desager, A. Geubel, 1994, Journal of hepatology.

Drugs recently released in Belgium: aztreonam, cefotetan, cefonicid.

C. Harvengt, 1986, Acta clinica Belgica.

Pharmacologic study of cefazolin in volunteers.

C. Harvengt, P. De Schepper, B. Boon, 1973, The Journal of clinical pharmacology and new drugs.

Drugs recently released in Belgium: goserelin--ofloxacin.

C. Harvengt, 1988, Acta Clinica Belgica.

Drugs recently released in Belgium. Foscarnet - pinacidil.

C. Harvengt, 1991, Acta clinica Belgica.

Nalidixic acid and urinary steroids.

C. Harvengt, M. Rousseau, M. Jeanjean, 1969, Clinica chimica acta; international journal of clinical chemistry.

Plasma kinetics of mitoxantrone in leukemic patients

C. Harvengt, E. Dumont, R. Hulhoven, 1984, Medical oncology and tumor pharmacotherapy.

Acute cardiovascular and renal changes induced by mitoxantrone in rabbits. A pharmacokinetic approach.

C. Harvengt, E. Dumont, R. Hulhoven, 1983, Toxicology letters.

Influence of repeated administration of cimetidine on the pharmacokinetics and pharmacodynamics of adinazolam in healthy subjects

J. Desager, C. Harvengt, R. Hulhoven, 2004, European Journal of Clinical Pharmacology.

The effect of cimetidine on the pharmacokinetics of single oral doses of alfuzosin.

P. Rosenzweig, G. Bianchetti, J. Desager, 1993, International journal of clinical pharmacology, therapy, and toxicology.

Naproxen Plasma Levels in Volunteers After Single‐Dose Administration by Oral and Rectal Routes

J. Desager, C. Harvengt, M. Vanderbist, 1976, Journal of clinical pharmacology.

Drugs recently released in Belgium. Epanolol--Clodronate dinatrium.

C. Harvengt, 1992, Acta clinica Belgica.

Prevalence of drug hydroxylator phenotypes in Belgium

J. Desager, C. Harvengt, Y. Nieuwenhuyze, 2004, European Journal of Clinical Pharmacology.

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

C. Harvengt, F. Heller, 2004, European Journal of Clinical Pharmacology.

Ritodrine serum levels: influence of dose and route of administration.

K. Thomas, J. Desager, C. Harvengt, 1984, International journal of clinical pharmacology, therapy, and toxicology.

Drugs recently released in Belgium. Guanabenz acetate, isotretinoin and etretinate.

C. Harvengt, 1986, Acta Clinica Belgica.

Total, free and HDL cholesterol determination in serum by GLC. A fast and accurate method

J. Desager, C. Harvengt, 1978 .

Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.

J. Desager, C. Harvengt, F. Heller, 1980, Artery.

Drugs recently released in Belgium. Recombinant DNA yeast-derived hepatitis B vaccine-terazosin.

C. Harvengt, 1988, Acta clinica Belgica.

Comparison of the Effect of Celiprolol and Nifedipine on Blood Pressure and Plasma Lipids

J. Staessen, A. Amery, L. Thijs, 1992, Journal of Cardiovascular Pharmacology.

Effect of fenofibrate and LF 2151 on hepatic peroxisomes in hamsters.

C. Harvengt, F. Heller, S. Pourbaix, 1984, Biochemical pharmacology.

A pharmacokinetic evaluation of the second‐generation H1‐receptor antagonist cetirizine in very young children

Y. Horsmans, J. Desager, C. Harvengt, 1993, Clinical pharmacology and therapeutics.

An improved gas‐liquid chromatographic method for determining practolol in plasma and urine

J. Desager, C. Harvengt, 1975, The Journal of pharmacy and pharmacology.

Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers

M. Longueville, J. Desager, C. Harvengt, 1997, Clinical pharmacology and therapeutics.

Effects of Combined Bezafibrate‐Simvastatin Appraised in Healthy Subjects

Y. Horsmans, J. Desager, C. Harvengt, 1992, Journal of clinical pharmacology.

The metabolic fate of14C or35S labelled tiadenol in rabbit after i.v. and oral administration

M. Sclavons, J. Desager, C. Harvengt, 1986, European Journal of Drug Metabolism and Pharmacokinetics.

LACK OF CLINICALLY RELEVANT INTERACTION OF CETIRIZINE ON THEOPHYLLINE DISPOSITION IN HEALTHY SUBJECTS: A PLACEBO‐CONTROLLED STUDY

J. Desager, C. Harvengt, R. Hulhoven, 1995, American journal of therapeutics.

Single‐Dose Pharmacokinetics of Cetirizine in Patients With Chronic Liver Disease

Y. Horsmans, C. Harvengt, R. Hulhoven, 1993, Journal of clinical pharmacology.

Drugs recently released in Belgium. Octreotide--roxithromycin.

C. Harvengt, 1989, Acta clinica Belgica.

Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins.

U. Gaspard, J. Desager, C. Harvengt, 1988, Contraception.

Effect of colestipol, a new bile acid sequestrant, on the absorption of phenprocoumon in man

J. Desager, C. Harvengt, 1973, European Journal of Clinical Pharmacology.

Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.

J. Desager, C. Harvengt, R. Hulhoven, 1985, International journal of clinical pharmacology, therapy, and toxicology.

Metabolic Interaction of Cimetidine With Alprazolam and Triazolam After Repeated Doses

J. Desager, C. Harvengt, E. Dumont, 1984 .

Cephradine absorption and excretion in fasting and nonfasting volunteers.

C. Harvengt, P. De Schepper, J. Hansen, 1973, The Journal of clinical pharmacology and new drugs.

Amitriptyline binding to specific alpha-adrenergic receptors in vitro.

J. Desager, C. Harvengt, J. P. Leonard, 1980, Life sciences.

Lack of interaction between zolpidem and H2 antagonists, cimetidine and ranitidine.

P. Hermann, J. Desager, C. Harvengt, 1988, International journal of clinical pharmacology research.

Daunorubicin-DNA complex in acute nonlymphoblastic leukemia

C. Peterson, C. Harvengt, R. Hulhoven, 2004, Cancer Chemotherapy and Pharmacology.

Distribution of daunorubicin intravenously injected or intravenously infused as free drug and as a complex with DNA in rabbits.

C. Harvengt, R. Hulhoven, 1982, Pharmacology.

Influence of the Hemodialysis on the Half‐Life of Practolol in Patients with Severe Renal Failure

J. Desager, C. Harvengt, R. Verberckmoes, 1975, Journal of clinical pharmacology.

Drugs recently released in Belgium: epirubicin and enalapril maleate.

C. Harvengt, 1985, Acta clinica Belgica.

Pharmacokinetics and Disposition of Nifedipine and Acebutolol As a Fixed Combination Or Given Separately After Single and Repeated Dose in Healthy-subjects

M. Sclavons, J. Desager, C. Harvengt, 1986 .

Lack of pharmacokinetic interaction of colestipol and fenofibrate in volunteers

J. Desager, C. Harvengt, 1980, European Journal of Clinical Pharmacology.

Drugs recently released in Belgium. Amlodipine besilate--encainide.

C. Harvengt, 1990, Acta clinica Belgica.

An improvement of Barter's method for assaying plasma cholesterol ester transfer activity: experimental and clinical applications.

J. Desager, C. Harvengt, F. Heller, 1989, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Fast separation of the three main plasma lipoprotein classes by ultracentrifugation using vertical rotor and multiple discontinuous density gradient.

M. Sclavons, J. Desager, C. Harvengt, 1985, Clinica chimica acta; international journal of clinical chemistry.

[Secondary drug-induced cholestasis with bile duct involvement].

Y. Horsmans, C. Harvengt, 1991, Acta gastro-enterologica Belgica.

Is there a link between debrisoquine oxidation phenotype and lung cancer susceptibility?

Y. Horsmans, J. Desager, C. Harvengt, 1991, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.

Y. Horsmans, J. Desager, C. Harvengt, 1989, International journal of clinical pharmacology, therapy, and toxicology.

Hypotriglyceridemic action of omega-3 fatty acids in healthy subjects does not occur by enhanced lipoprotein lipase and hepatic lipase activities.

J. Dricot, J. Desager, C. Harvengt, 1989, Research communications in chemical pathology and pharmacology.

Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).

A. Amery, R. Fagard, C. Harvengt, 1975, Archives internationales de pharmacodynamie et de therapie.

Absolute bioavailability of mianserin tablets and solution in healthy humans

M. Sclavons, J. Desager, C. Harvengt, 1985, European Journal of Drug Metabolism and Pharmacokinetics.

Plasma levels and biotransformation of infused daunorubicin and daunorubicin-DNA complex in rabbits: a preliminary report.

J. Desager, C. Harvengt, R. Hulhoven, 1977, European journal of cancer.